Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Dec 27, 2022 (4 years ago)

Imipenem/Cilastatin 2000mg in Ns 400ml

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of sterility assurance

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

IMIPENEM/CILASTATIN 2000MG IN NS 400ML, antibiotic, Rx Only, use with a Curlin Pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320, NDC# 63323-0322-25

Affected NDC 63323-0322-25

Compare with the code on your package — it is the most precise check available.

Drug: Cilastatin

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Imipenem and Cilastatin
Imipenem and Cilastatin Sodium
NDC 63323-0322
IMIPENEM 500 mg/20mL; CILASTATIN SODIUM 500 mg/20mL Injection, Powder, for Solution
Intravenous
Fresenius Kabi USA, LLC Rx
Recalling firm
Sentara Infusion Services
NDC code
63323-0322-25
Origin
VA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0297-2023 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Cilastatin recalls

See all

Other recalls by Sentara Infusion Services

All 2022 recalls